FFAR4 Deficiency Increases Necrotic Cores in Advanced Lesions of ApoE-/- Mice-Brief Report

Gage M Stuttgen1,2,3, Jordan M Bobek1,2, Renee Penoske2,4

  • 1Department of Biochemistry (G.M.S., J.M.B., M.L., S.N.H., D.S.), Medical College of Wisconsin, Milwaukee.

Abstract

Insights

Mice lacking free fatty acid receptor 4 (FFAR4) showed reduced early plaque but increased advanced plaque and necrotic cores. FFAR4 deficiency appears to worsen atherosclerosis, particularly in later stages.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Metabolic Disease Research

Background:

  • Free fatty acid receptor 4 (FFAR4) is a potential target for cardiovascular disease prevention.
  • FFAR4 activation is known to protect against arterial plaque buildup.
  • FFAR4 influences macrophage inflammation and foam cell formation.

Purpose of the Study:

  • To investigate the role of FFAR4 deficiency in the development of atherosclerosis.
  • To test the hypothesis that FFAR4 deficiency exacerbates atherosclerotic plaque development in apolipoprotein E-deficient (apoE-/-) mice.

Main Methods:

  • Male and female apoE-/-/Ffar4-/- mice and apoE-/- controls were fed a Western diet for 8 or 16 weeks.
  • Atherosclerotic lesion severity was assessed by measuring aortic sinus and aortic arch lesion areas.
  • Necrotic core areas were quantified in advanced lesions.

Main Results:

  • After 8 weeks, apoE-/-/Ffar4-/- mice showed reduced aortic sinus lesions.
  • After 16 weeks, male apoE-/-/Ffar4-/- mice exhibited increased aortic arch plaque area.
  • FFAR4 deficiency led to significantly larger necrotic cores in both male and female mice.

Conclusions:

  • FFAR4 plays a protective role in stabilizing atherosclerotic plaques.
  • FFAR4 deficiency promotes the development of necrotic cores, indicating plaque instability.
  • These findings highlight FFAR4 as a novel therapeutic target for mitigating advanced atherosclerosis.